20/20 GeneSystems, Inc.

20/20 GeneSystems, Inc. logo via Clearbit

Profile

According to their SEC filings, 20/20 GeneSystems, Inc. is a Corporation organized in DE on 09-28-2000. They report having 12 employee(s), and revenue in their most-recent fiscal year of $313,207.00 and $427,001.00 the prior year.

Company Description

"20/20 GeneSystems (‘20/20’) was founded in May of 2000 to develop and promote an innovative proteomics product line that provides drug companies, biodefense specialists and life scientists with new tools for protein analysis. Our headquarters are in th..."

Website: http://www.2020gene.com

Sector: Industrials

Industry: Professional Services

Twitter: 2020Gene

Facebook: 595512853824044

LinkedIn: 20-20-genesystems

Location

9430 KEY WEST AVE.

ROCKVILLE, MD 20850

Equity Crowdfunding Campaigns

Reg CF Offering from 20/20 GeneSystems, Inc. (Previous)

Campaign Details

According to their SEC filings, 20/20 GeneSystems, Inc. previously ran a Regulation Crowdfunding campaign to raise $0.00 (up to a maximum of $0.00) in via before a deadline of .

As compensation for managing the offering, reported being compensated as follows:

In addition to any direct compensation, 20/20 GeneSystems, Inc. reported that would also receive the following financial interest in the offering:

More information about this issuer may also be available via Crowditz.com, including information about weekly and aggregate investor commitments.

Financial Information

The following information is taken directly from SEC filings.

Income Statement Items

Most Recent Fiscal Year Prior Fiscal Year
Revenue $313,207.00 $427,001.00
Cost of Goods Sold $182,275.00 $256,221.00
Taxes Paid $0.00 $0.00
Net Income $-1,264,194.00 $-2,228,052.00

Balance Sheet Items

Most Recent Fiscal Year Prior Fiscal Year
Total Assets $0.00 $0.00
Cash and Cash Equivalents $1,040,083.00 $982,225.00
Accounts Receivable $53,106.00 $44,217.00
Short-term Debt $964,437.00 $560,453.00
Long-term Debt $1,500.00 $1,500.00

Complete Reg CF filings list for 20/20 GeneSystems, Inc.

  • [2018-08-14T15:08:31+00:00] 20/20 GeneSystems, Inc. filed a Form C-AR.

    File number: 020-23669

  • [2018-08-13T16:06:06+00:00] 20/20 GeneSystems, Inc. filed a Form C-AR-W.

    File number: 020-23669

  • [2018-08-13T15:31:28+00:00] 20/20 GeneSystems, Inc. filed a Form C-AR.

    File number: 020-23669

  • [2017-12-14T13:30:03+00:00] 20/20 GeneSystems, Inc. filed an amended Form C (Form C/A) regarding their offering to raise a target of $74,999.56 via Microventures. The nature of the amendment was described as follows:

    This Amendment is filed to add the Webinar Transcript (Exhibit I)

    File number: 020-23669

  • [2017-10-30T17:15:26+00:00] 20/20 GeneSystems, Inc. filed an amended Form C (Form C/A) regarding their offering to raise a target of $74,999.56 via Microventures. The nature of the amendment was described as follows:

    Correct nonmaterial typographical errors in the Company Summary, the Subscription Agreement and the Certificate of Designation of Series A-2 Preferred Stock, and make a nonmaterial clarification to Section 7.3 of the Certificate of Designation.

    File number: 020-23669

  • New Filing Form C

    [2017-10-13T17:16:06+00:00] 20/20 GeneSystems, Inc. filed a Form C to raise a target amount of $74,999.56 (up to a maximum of $1,070,000.00) of via Microventures.

    File number: 020-23669